an open multicentric pediatric clinical trial has been performed to evaluate the safety and efficacy of astemizole ( hismanal suspension ) at a 1 ml ( 2 mg ) dosage per 10 kg body weight once daily in children with chronic urticaria .
C0085170
astemizole
C0699606
hismanal